168 related articles for article (PubMed ID: 34789272)
1. Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis.
Thomas S; Fayet OM; Truffault F; Fadel E; Provost B; Hamza A; Berrih-Aknin S; Bonnefont JP; Le Panse R
J Neuroinflammation; 2021 Nov; 18(1):270. PubMed ID: 34789272
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of miR-29 family associated with autoimmune myasthenia gravis.
Cron MA; Payet CA; Fayet OM; Maillard S; Truffault F; Fadel E; Guihaire J; Berrih-Aknin S; Liston A; Le Panse R
J Neuroinflammation; 2020 Oct; 17(1):294. PubMed ID: 33032631
[TBL] [Abstract][Full Text] [Related]
3. Analysis of microRNA expression in the thymus of Myasthenia Gravis patients opens new research avenues.
Cron MA; Maillard S; Delisle F; Samson N; Truffault F; Foti M; Fadel E; Guihaire J; Berrih-Aknin S; Le Panse R
Autoimmun Rev; 2018 Jun; 17(6):588-600. PubMed ID: 29655674
[TBL] [Abstract][Full Text] [Related]
4. Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations?
Salat U; Bardoni B; Wöhrle D; Steinbach P
J Med Genet; 2000 Nov; 37(11):842-50. PubMed ID: 11073538
[TBL] [Abstract][Full Text] [Related]
5. Increased number of Hassall's corpuscles in myasthenia gravis patients with thymic hyperplasia.
Matsui N; Ohigashi I; Tanaka K; Sakata M; Furukawa T; Nakagawa Y; Kondo K; Kitagawa T; Yamashita S; Nomura Y; Takahama Y; Kaji R
J Neuroimmunol; 2014 Apr; 269(1-2):56-61. PubMed ID: 24556356
[TBL] [Abstract][Full Text] [Related]
6. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy.
Sempowski GD; Hale LP; Sundy JS; Massey JM; Koup RA; Douek DC; Patel DD; Haynes BF
J Immunol; 2000 Feb; 164(4):2180-7. PubMed ID: 10657672
[TBL] [Abstract][Full Text] [Related]
7. Galectin-1 is expressed by thymic epithelial cells in myasthenia gravis.
Hafer-Macko C; Pang M; Seilhamer JJ; Baum LG
Glycoconj J; 1996 Aug; 13(4):591-7. PubMed ID: 8872116
[TBL] [Abstract][Full Text] [Related]
8. Primary cultures of human myasthenia gravis thymus and normal thymus. Studies of cell morphology, cell proliferative pattern and localization of alpha-bungarotoxin binding sites on cultured thymic cells.
Matsumoto Y; Furuya A; Kobayashi T; Tsukagoshi H
J Neurol Sci; 1986 Sep; 75(2):121-33. PubMed ID: 3760907
[TBL] [Abstract][Full Text] [Related]
9. Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity.
Cordiglieri C; Marolda R; Franzi S; Cappelletti C; Giardina C; Motta T; Baggi F; Bernasconi P; Mantegazza R; Cavalcante P
J Autoimmun; 2014 Aug; 52():74-89. PubMed ID: 24397961
[TBL] [Abstract][Full Text] [Related]
10. Il-23/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis.
Villegas JA; Bayer AC; Ider K; Bismuth J; Truffault F; Roussin R; Santelmo N; Le Panse R; Berrih-Aknin S; Dragin N
J Autoimmun; 2019 Mar; 98():59-73. PubMed ID: 30578016
[TBL] [Abstract][Full Text] [Related]
11. Central role of interferon-beta in thymic events leading to myasthenia gravis.
Cufi P; Dragin N; Ruhlmann N; Weiss JM; Fadel E; Serraf A; Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():44-52. PubMed ID: 24393484
[TBL] [Abstract][Full Text] [Related]
12. miR-146a in Myasthenia Gravis Thymus Bridges Innate Immunity With Autoimmunity and Is Linked to Therapeutic Effects of Corticosteroids.
Bortone F; Scandiffio L; Marcuzzo S; Bonanno S; Frangiamore R; Motta T; Antozzi C; Mantegazza R; Cavalcante P; Bernasconi P
Front Immunol; 2020; 11():142. PubMed ID: 32210951
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors.
Kirchner T; Tzartos S; Hoppe F; Schalke B; Wekerle H; Müller-Hermelink HK
Am J Pathol; 1988 Feb; 130(2):268-80. PubMed ID: 2449082
[TBL] [Abstract][Full Text] [Related]
14. Expression of RAGE and HMGB1 in thymic epithelial tumors, thymic hyperplasia and regular thymic morphology.
Moser B; Janik S; Schiefer AI; Müllauer L; Bekos C; Scharrer A; Mildner M; Rényi-Vámos F; Klepetko W; Ankersmit HJ
PLoS One; 2014; 9(4):e94118. PubMed ID: 24705787
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
[TBL] [Abstract][Full Text] [Related]
16. Identification of human thymic epithelial cells with antibodies to thymosin alpha 1 in myasthenia gravis.
Dalakas MC; Engel WK; McClure JE; Goldstein AL; Askanas V
Ann N Y Acad Sci; 1981; 377():477-85. PubMed ID: 7041758
[TBL] [Abstract][Full Text] [Related]
17. The overexpression of Fra1 disorders the inflammatory cytokine secretion by mTEC of myasthenia gravis thymus.
Li QR; Ni WP; Lei NJ; Yang JY; Xuan XY; Liu PP; Gong GM; Yan F; Feng YS; Zhao R; Du Y
Scand J Immunol; 2018 Jul; 88(1):e12676. PubMed ID: 29807388
[TBL] [Abstract][Full Text] [Related]
18. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis.
Poëa-Guyon S; Christadoss P; Le Panse R; Guyon T; De Baets M; Wakkach A; Bidault J; Tzartos S; Berrih-Aknin S
J Immunol; 2005 May; 174(10):5941-9. PubMed ID: 15879086
[TBL] [Abstract][Full Text] [Related]
19. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays.
Sølvsten C; Nielsen AL
Gene; 2011 Oct; 486(1-2):15-22. PubMed ID: 21767618
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
